Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants
Clinical trial NCT03881696 · COMPLETED
Trial details
- NCT number
- NCT03881696
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-22
- Primary completion
- 2023-03-13
- Enrollment
- 471
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.